Direktorat Registrasi ObatValid

CEFOTAXIME SODIUM

Claim this product
BPOM Number
GKL1613320244A1
Approved
21 November 2024
Expiry
26 September 2028
Form
SERBUK INJEKSI; 1.1 G

About This Registration

CEFOTAXIME SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1613320244A1. Its current registration status is Valid, with the licence valid until 26 September 2028. The product is registered to LAPI LABORATORIES - INDONESIA. BPOM first approved this registration in August 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 2 VIAL @ 1 G
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

CEFOTAXIME SODIUM

Market Intelligence

Owner Portfolio
LAPI LABORATORIES - INDONESIA holds 249 BPOM registrations
Manufacturer Scale
LAPI LABORATORIES - INDONESIA produces 249 registered products
Registration Age
Registered for 2 years, 1 month

FDA Cross-Reference

via openFDA
Generic Name
CEFOTAXIME INJECTION
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1